New Hope Genetics

New Hope Genetics is focused on advanced therapy trails targeting genetic disorders utilizing the cutting edge of technology. Our company goal is to cure genetic disease by collecting irrefutable data and developing proprietary treatment protocols. By establishing clear protocols with peer reviewed and published scientific data, New Hope Genetics will pioneer the new era of medicine utilizing exsosomes, CRISPR gene editing and nutraceutical based products. Our next IND study set for spring 2021 will be utilizing intravenous infusion of a proprietary blend of exosome proteins and growth factors derived from placenta fluids targeting neurodegeneration of brain cells within the basal ganglia caused by Huntington's Disease. In 2021, New Hope Genetics plans on developing several IND and IRB trials targeting genetic disorders including but not limited to; Parkinson's Disease, Colon Cancer, Kidney Disease, Liver Disease, Degenerative Disc Disorder, Lupus, Diabetes, Pulmonary Disease (COPD) and more.